For research use only. Not for therapeutic Use.
Viloxazine (CAS 46817-91-8) is a pharmaceutical compound known for its varied pharmacological properties. Originally developed as an antidepressant, Viloxazine also exhibits unique characteristics, including its influence on norepinephrine reuptake and alpha-2 adrenergic receptors. While it was initially employed for treating depressive disorders, its usage has expanded to explore potential applications in other therapeutic areas, such as attention-deficit hyperactivity disorder (ADHD).
| Catalog Number | I048018 |
| CAS Number | 46817-91-8 |
| Synonyms | 2-[(2-ethoxyphenoxy)methyl]morpholine |
| Molecular Formula | C13H19NO3 |
| Purity | 98% |
| Target | Norepinephrine reuptake |
| Target Protein | YWPHCCPCQOJSGZ-UHFFFAOYSA-N |
| Appearance | Solid |
| IC50 | The inhibitory constant (Ki) for viloxazine at the norepinephrine transporter (NET) is 0.63 μM |
| IUPAC Name | 2-[(2-ethoxyphenoxy)methyl]morpholine |
| InChI | InChI=1S/C13H19NO3/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11/h3-6,11,14H,2,7-10H2,1H3 |
| InChIKey | YWPHCCPCQOJSGZ-UHFFFAOYSA-N |
| SMILES | CCOC1=CC=CC=C1OCC2CNCCO2 |
